170446 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Hormones Calcitonin gene related peptide
Vaccines and Antibodies for the Treatment and Prevention of Neurodegenerative Disorders and Inflammation Related Health Conditions
#2PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#3EARLY DIAGNOSIS OF INFECTIONS
#4ADM2 GENE MARKER FOR DIAGNOSIS OR PROGNOSIS PREDICTION OF THYROID CANCER AND USES THEREOF
#5SEPSIS MANAGEMENT
#6Early diagnosis of infections
#7METHODS OF DETECTING SEPTIC ARTHRITIS, TRANSIENT SYNOVITIS AND OSTEOMYELITIS
#8Protein signatures for distinguishing between bacterial and viral infections
#9Methods of treating inflammatory skin disorders
#10ADM2 GENE MARKER FOR DIAGNOSIS OR PROGNOSIS PREDICTION OF THYROID CANCER AND USES THEREOF
#11Regulation of glucose metabolism using anti-CGRP antibodies
#12Biomarker detection system
#13Early diagnosis of infections
#14Protein signatures for distinguishing between bacterial and viral infections
#15IMMUNOASSAY FOR THE DETECTION OF PROCALCITONIN
#16Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
#17Device and method for point-of-care diagnostics and antibiotic resistance identification, and applications thereof
#18SIGNATURES AND DETERMINANTS FOR DIAGNOSING INFECTIONS IN NON-HUMAN SUBJECTS AND METHODS OF USE THEREOF
#19Immunoassay for the detection of procalcitonin
#20Use of CGRP antagonist compounds for treatment of psoriasis
#21Use of CGRP antagonist compounds for treatment of psoriasis
#22IMMUNOASSAY FOR THE DETECTION OF PROCALCITONIN
#23DETECTION OF NEUROPEPTIDES ASSOCIATED WITH PELVIC PAIN DISORDERS AND USES THEREOF
#24USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS
#25Diagnosis and treatment of wound infection with procalcitonin as diagnostic marker
#26Detection of neureopeptides associated with pelvic pain disorders and uses thereof